Publications by authors named "Christopher Hebbes"

Claim this Profile
D
Disseminated Hypervirulent Klebsiella pneumoniae Infection Following Travel: A Case of Cavitating Pneumonia, Hepatic and Renal Abscesses, and Thrombosis.
Konstantinos Baronos, Simon Scott, Christopher Hebbes

Cureus· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cells.
Mark F Bird, Christopher P Hebbes, Anushuya Tamang, Jonathon Mark Willets, Jonathan P Thompson

Br J Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.
Zoë L S Brookes, Emily N Stedman, Nicola J Brown, Christopher P Hebbes, Remo Guerrini

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of severity and survival in acute pancreatitis: validation of the efficacy of early warning scores.
Giuseppe Garcea, Mohammed Gouda, Christopher Hebbes, Seok Ling Ong, Christopher P Neal

Pancreas· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies.
Raffaella Vergura, Elena Valenti, Christopher P Hebbes, Elaine C Gavioli, Barbara Spagnolo

Peptides· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist.
Claudio Trapella, Remo Guerrini, Laura Piccagli, Girolamo Calo', Giacomo Carra', Christopher Hebbes

Bioorg Med Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
Giacomo Carrà, Anna Rizzi, Remo Guerrini, Timothy A Barnes, John McDonald, Christopher P Hebbes

J Pharmacol Exp Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis